Document is current
Any future updates will be listed below
-
Authors
Autilio, Chiara
Touqui, Lhousseine
Foligno, Silvia
Arroyo, Raquel https://orcid.org/0000-0003-0612-3928
Kingma, Paul S. https://orcid.org/0000-0001-7065-8711
Alonso, Alejandro A.
Perez-Gil, Jesus
De Luca, Daniele https://orcid.org/0000-0002-3846-4834
- License Information
-
More Information
Article History
Received: 30 September 2024
Revised: 11 March 2025
Accepted: 25 March 2025
First Online: 2 April 2025
Competing interests
: PSK served as Chief Medical Officer from 2018-2021 for Airway Therapeutics inc. which is developing SPD as a human therapeutic agent; all his financial relationships with Airway Therapeutics inc. terminated in 2021. RA is currently an employee of Airway Therapeutics inc. JPG and DDL received research grants or consultancy fees from Airway Therapeutics inc. This company had no role whatsoever in design, preparation and conduction or review of the work, neither in the approval of the manuscript or decision to submit it for publication. The declared interests are all unrelated to the present work. The other authors have no conflicts of interest to disclose.
